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Abstract
To obtain an insight into the mechanisms responsible for GLUT5 diurnality and fructose responsiveness, rats were
gavaged at 9:00 AM or 6:00 PM with 1 g of fructose in the presence or absence of cycloheximide. After 4 h of fructose
exposure, GLUT5 mRNA and protein levels increased 2–3.5-fold above the natural diurnal levels of expression. In situ
hybridization and immunochemical analysis of GLUT5 mRNA and protein demonstrated that both diurnality and fructose
responsiveness was confined to mature enterocytes. The protein synthesis inhibitor, cycloheximide, blunted the diurnal and
fructose driven increase in GLUT5 mRNA expression in the morning, but had minimal effect on the pattern of expression in
the evening. This differential sensitivity of intestinal GLUT5 mRNA to de novo protein synthesis may reflect the increasing
presence of diurnal and fructose sensitive control factors during the day. Following vehicle gavage, Cycloheximide was
more effective in reducing GLUT5 protein expression levels in the morning when compared to the evening. These data
suggest that the turnover of GLUT5 protein may be diurnally influenced. q 1998 Elsevier Science B.V.
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1. Introduction
Small intestinal transport of hexoses is achieved
w xvia SGLT1, GLUT5 and GLUT2 proteins 1 . Brush-
border SGLT1 is responsible for the luminal absorp-
w xtion of glucose and galactose 2 while GLUT5 has
been formally identified as the brush-border fructose
w xtransporter 3–5 . Basolateral GLUT2 mediates the
exit of all three hexoses from the enterocyte into the
w xmesentery 6,7 . Numerous studies have demonstrated
the small intestinal sugar transporters to be regulated
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w x w xat a developmental 5 diurnal 8–10 and dietary
w xlevel 10–13 as well as following STZ-induced dia-
w xbetes 9,14,15 .
The rat intestine upregulates the hexose trans-
porters prior to the onset of feeding. This diurnal
pattern of expression appears to be hard wired in
nature because GLUT5 is upregulated in the absence
w xof dietary fructose 10 . The phenomena of diurnality
has also been linked to the daily differentiation pro-
cess, whereby crypt cells migrate passed the crypt-
villus junction and mature into functional enterocytes
w x16,17 . The crypts are also thought to be the initial
w xsite for dietary perception 12,18 . However, when
rodents are exposed to dietary fructose, intestinal
GLUT5 mRNA and protein are upregulated in a
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xmatter of hours 10,11 suggesting a more limited role
for the crypts during the acute phase of dietary
adaptation.
The epithelial cells along the crypt-villus axis that
are responsible for GLUT5 diurnality and acute fruc-
tose responsiveness are unknown. In addition, the
molecular mechanisms responsible for controlling
GLUT5 transporter expression are unknown, al-
though there is evidence that SGLT1 and GLUT2
transcriptional activity is stimulated by carbohydrate
w xfeeding 19 . The current study was therefore under-
taken in order to obtain further insight into the con-
trol of GLUT5 expression.
Fructose or vehicle was administered to Sprague–
Dawley rats in the morning, when GLUT5 levels are
near their lowest, and in the evening, when the
natural diurnal rhythm has increased GLUT5 mRNA
w xand protein levels significantly 10 . We hypothesize
that the control factors responsible for GLUT5 diur-
nality will be in abundance around mid to late after-
noon. The protein synthesis inhibitor cycloheximide,
previously employed to dissect intestinal function
w x20–23 , was used to assess the importance of de
novo protein synthesis towards GLUT5 control at
different times of the day. Northern and Western
blots were undertaken to quantitate the changes in
GLUT5 mRNA and protein during the day and fol-
lowing exposure to fructose and cycloheximide. In
situ hybridization of GLUT5 mRNA and immunohis-
tochemistry of GLUT5 and GLUT2 protein were
performed to establish the cell populations responsi-
ble for diurnality and fructose driven expression.
2. Methods
2.1. Animals
 .Male Sprague–Dawley rats 175 g were housed in
a 12:12 h light–dark cycle room with free access to
water and Teklad 7001 mouserrat diet. On average
13–15 gr175 g ratrday of control Teklad diet was
consumed with approximately 1.3–1.8 gr175 g ratr
day of food being consumed during the light period
 .6:00 AM–6:00 PM .
2.2. Ga˝age feeding experiments
Rats were lightly anesthetized with metafane at
9:00 AM or 6:00 PM and gavaged with either 1 ml of
0.9% saline or 1 g fructose in 0.9% saline through a
small polypropylene tube introduced into the stom-
 .ach. In some experiments and 30 min before gavage
2.5 mgrkg rat of cycloheximide in PBS was adminis-
tered by intraperitoneal injection. After all treatments,
the animals were allowed free access to water, but
denied food. At 1:00 and 10:00 PM i.e., 4 h after the
.9:00 AM and 6:00 PM gavages , the animals were
killed and their jejuna removed.
2.3. Post-nuclear membrane preparation
Fifteen cm of jejunal mucosa was isolated and
1–1.5 g of mucosa homogenized in ice-cold PBS
containing 1 mM PMSF, pH 7.4. The resultant ho-
mogenate was then centrifuged at 900=g for 3 min
and the supernatant removed and recentrifuged at
32 000=g for 15 min at 48C. The pellet was resus-
pended in homogenization buffer and recentrifuged at
32 000=g for 15 min. The final pellet was resus-
pended in PBS, 1 mM PMSF, pH 7.4 and assayed for
protein content by the Bio-rad micro-assay method.
2.4. Western blotting
 .Protein 50 mg was separated on a 10% SDS
resolving gel and transblotted overnight onto Immo-
 .bilon-P membranes Millipore . The membranes were
then blocked in TTBS containing 5% Carnation In-
stant Milk and immunoblotted with 1:500 diluted
w xsolution of rabbit anti-rat GLUT5 sera 5 . The pri-
mary antibody was conjugated to 125I-protein A and
then autoradiographed overnight using Kodak XAR
film. The autoradiographs were then quantitated us-
 .ing a Hewlett-Packard Scan Jet 11c 400 dotsrin. as
w xpreviously described 11 . In all GLUT5 blots, a
single immunoreactive band was observed at approxi-
mately 60 kDa.
2.5. RNA isolation and quantitation
 .Mucosal scrapings 0.5 g were homogenized in 4
M guanidium thiocyanate, 0.5% N-laurylsarcosine
and 25 mM sodium citrate, pH 7.0. The method used
for total RNA isolation has been previously described
w xby Chomczynski and Sacchi 24 but included addi-
 .tional washes with 4 M LiCl. RNA 10 mg was
subjected to electrophoresis on 1% agarose–6% for-
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maldehyde gel and transferred to nylon membranes
overnight by capillary action. The membranes were
UV-crosslinked and hybridized overnight at 428C
32 w xwith P-labeled GLUT5 cDNA 11 . The membranes
were washed in 0.1= SSC SSC is 150 mM NaCl,
.15 mM sodium citrate, pH 7.0 and 0.1% SDS for 30
min at room temperature and at 568C in the same for
30 min. In all GLUT5 mRNA blots, a single band
was obtained at approximately 2.1 kb. The blots were
autoradiographed and quantitated as described in the
Western blotting section. All GLUT5 mRNA blots
were normalized against GAPDH.
2.6. In situ hybridization experiments
A 470-bp Pst 1 fragment of rat GLUT5 cDNA was
subcloned into pGEM-3Z and linearized with either
 .  .Bam HI sense probe or Hind III anti-sense probe .
Digoxigenin-riboprobes were synthesized by the ad-
dition of digoxigenin-labeled UTP in the Maxi-script
 .in vitro mRNA synthesis reaction Ambion . In situ
hybridizations were performed according to the pro-
w xtocol described by Simmons et al. 25 . In brief,
jejunal samples obtained from control and fructose
exposed tissue were fixed in sterile 4% paraformal-
dehyde for 4 h, followed by an overnight incubation
in 4% paraformaldehyder15% sucrose solution at
 .48C. Sections 15 mm were hybridized with Dig-UTP
w xriboprobes 500 ngrml in hybridization solution
50% Formamide, 15% Denhardts, 10% Dextran Sul-
 .  .phate, 1 mM Tris pH 8.0 10 mM EDTA pH 8.0
.and 10 mgrml tRNA overnight at 558C. Unbound
probe was washed from the sections using 2=SSC
for 15 min followed by 0.1= SSC at 558C for 15
min. Bound Dig-UTP probe was colorimetrically de-
tected following a 6-h incubation with NBTrX-Phosp
as described by the manufacturers protocol Boeh-
.ringer-Mannheim . Visualization of the signal was
undertaken using an Olympus BH-2 and photo-
graphic images captured on Kodak Ektachrome E6
film.
2.7. Immunohistochemical analysis
Jejunal sections were obtained from control and
fructose exposed tissue and fixed overnight in Bouin’s
and 10% formaldehyde. Immunohistochemical analy-
sis was carried out according to the Vectastain proto-
 .col. In brief, paraffin embedded sections 5 mm
were deparaffinized by a 30 min incubation at 588C
followed by a series of 3 min xylene and ethanol
washes. Sections were washed sequentially at room
temperature in 0.3% H O in PBS for 30 min; 502 2
mM glycinerPBS for 5 min; blocking buffer 2%
 .normal goat serum NGS r1% BSAr1%
.gelatinr0.1% Triton X-100 in PBS for 30 min and
0.1= blocking buffer containing 2% NGS for 5 min.
 .Anti-rat GLUT5 or GLUT2 sera 1:500 dilution in
0.1= blocking bufferr2% NGS was applied to each
section and incubated overnight at 48C in a humidi-
fied chamber. The sections were washed in PBS and
incubated for 1 h at room temperature with a 1:100
biotinylated goat anti-rabbit solution in 2%
NGSrPBS in a humidified chamber. The sections
were washed in PBS for 15 min and incubated in the
manufacturers supplied ABC reagent solution. Detec-
tion of antigen–antibody conjugates was achieved by
staining sections with 0.1% DABr0.2% hydrogen
peroxide solution for 3–5 min followed by counter-
staining with hematoxylin. The viewing of the sec-
tions is as described in the in-situ hybridization sec-
tion.
3. Results
Preliminary studies showed an increase in GLUT5
mRNA and protein expression levels after 2 h of
fructose exposure, with a reproducible maximum ob-
 .tained after 4 h data not shown . Thereafter, rats
were gavaged at 9:00 AM or 6:00 PM and their
jejuna isolated 4 h later at 1:00 PM and 10:00 PM,
respectively. All GLUT5 mRNA Northern blot data
was normalized against GAPDH mRNA. No varia-
tion in GAPDH mRNA expression levels was ob-
served with time or in response to fructose or cyclo-
heximide.
3.1. Effect of PBS, fructose and cycloheximide on
‘morning’ GLUT5 expression
Consistent with the previously observed diurnal
w xincrease in expression 10 , GLUT5 mRNA steady
state levels increased approximately 2.5-fold between
9:00 AM and 1:00 PM in animals gavaged with PBS
 .Fig. 1 . Exposure to 1 g of fructose for 4 h between
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Fig. 1. Effects of fructose on morning GLUT5 mRNA levels in
 .the presence of cycloheximide. A Relative levels of GLUT5
mRNA after normalization with GAPDH mRNA. Values are
 .mean"SEM of at least 6 animals. B Representative autoradio-
 .grams showing GLUT5 mRNA expression. C Representative
autoradiograms showing GAPDH mRNA levels. ) s
Significantly different from control PBS-gavaged levels mea-
 .sured at 1:00 PM P -0.05 . asLevels of GLUT5 mRNA
induced by fructose in the presence of inhibitor which are
significantly different from GLUT5 mRNA levels obtained with
 .fructose alone P -0.05 .
9:00 AM and 1:00 PM increased GLUT5 mRNA
levels by 2.5–3-fold above 1:00 PM vehicle values
 .Fig. 1 . Pretreatment with cycloheximide blunted the
diurnal and fructose driven increase in GLUT5 mRNA
expression by 40 and 70%, respectively.
GLUT5 protein levels, following a PBS gavage,
remained unchanged between 9:00 AM and 1:00 PM
 .Fig. 2 . When compared to the PBS-gavaged con-
trols, exposure of rats to 1 g of fructose for 4 h
resulted in an approximately twofold increase in
GLUT5 protein levels by 1:00 PM. As can be seen in
the autoradiograph, there are additional lower molec-
 .ular weight bands arrows in Fig. 2 immunoreacting
with the GLUT5 antisera after fructose gavage. These
bands may represent partially and non-glycosylated
protein indicating de novo synthesis. Pretreatment
with cycloheximide before PBS or fructose gavage
decreased the levels of GLUT5 protein by approxi-
mately 75% when compared to control 1:00 PM
 .levels Fig. 2 .
Fig. 2. Effects of fructose on morning GLUT5 protein levels in
 .the presence of cycloheximide. A Relative levels of GLUT5
 .protein. Values are mean"SEM of at least 6 animals. B
Representative autoradiograms showing GLUT5 protein levels.
)sSignificantly different from control PBS-gavaged levels
 .measured at 1:00 PM P -0.05 . asLevels of GLUT5 protein
induced by fructose in the presence of inhibitor which are
significantly different to GLUT5 protein levels obtained with
 .fructose alone P -0.05 .
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3.2. Effect of PBS, fructose and cycloheximide on
‘e˝ening’ GLUT5 expression
Between 6:00 and 10:00 PM, GLUT5 mRNA
 .steady state levels declined by 50% Fig. 3 . Cyclo-
heximide had no significant effect on the 6:00–10:00
 .PM decline in GLUT5 mRNA levels Fig. 3 . Rats
gavaged at 6:00 PM with 1 g of fructose demon-
strated a 3–3.5-fold rise in jejunal GLUT5 mRNA by
Fig. 3. Effects of fructose on evening GLUT5 mRNA levels in
 .the presence cycloheximide. A Relative levels of GLUT5 mRNA
after normalization with GAPDH mRNA levels. Values are mean
 ."SEM of at least 6 animals. B Representative autoradiograms
 .showing GLUT5 mRNA levels. C Representative autoradio-
grams showing GAPDH mRNA expression. )sSignificantly
different from control PBS-gavaged levels measured at 10:00 PM
 .P -0.05 . asLevels of GLUT5 mRNA induced by fructose in
the presence of inhibitor which are significantly different from
 .GLUT5 mRNA levels obtained with fructose alone P -0.05 .
Fig. 4. Effects of fructose on evening GLUT5 protein levels in
 .the presence of cycloheximide. A Relative levels of GLUT5
 .protein. Values are mean"SEM of at least 6 animals. B
Representative autoradiograms showing GLUT5 protein levels.
)sSignificantly different from control PBS-gavaged levels
 .measured at 10:00 PM P -0.05 . asLevels of GLUT5 protein
induced by fructose in the presence of inhibitor which are
significantly different in comparison with GLUT5 protein levels
 .obtained in the presence of fructose alone P -0.05 .
10:00 PM as compared to the 10:00 PM PBS gavage
values. In contrast to the morning, cycloheximide did
not significantly inhibit the fructose-induced rise in
 .GLUT5 mRNA levels Fig. 3 .
Despite the decreasing mRNA levels, GLUT5 pro-
tein levels remained unaltered between 6:00 and 10:00
 .PM Fig. 4 . Four hours after cycloheximide was
administered, no significant effect on GLUT5 protein
levels was observed when compared to the 10:00 PM
PBS gavage. Fructose increased the levels of GLUT5
protein 1.8-fold over 10:00 PM PBS controls. In the
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 .  .  . Fig. 5. In situ hybridization of rat GLUT5 mRNA. A Control 9:00 AM. B Control 1:00 PM. PBS gavage. C Fructose 1:00 PM after
.  .  .  .  .  .4 h fructose gavage . D Control 6:00 PM. E Control 10:00 PM. PBS gavage. F Fructose 10:00 PM after 4 h fructose gavage . G
Representative light micrograph of tissue probed at 9:00 AM with sense rGLUT5 cRNA Dig-UTP riboprobe.
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 .  .Fig. 6. Immunohistochemical localization of rat jejunal GLUT5 and GLUT2 protein. A, B control GLUT5 protein at 9:00 AM. C, D
 .  .GLUT5 protein at 1:00 PM after 4 h fructose gavage. E GLUT5 protein at 10:00 PM after 4 h fructose gavage. F, G Representative
staining pattern of GLUT2 protein expression obtained from jejuna exposed to fructose for 4 h and isolated at 1:00 PM.
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presence of inhibitor, GLUT5 protein levels were
 .unaltered after fructose exposure Fig. 4 .
3.3. Epithelial localization of GLUT5 mRNA expres-
sion
In situ hybridization analysis of GLUT5 mRNA
expression between 9:00 AM and 1:00 PM demon-
strated a punctate signal in the lower to mid-villus
 .regions Fig. 5A and B, respectively . Between 6:00
and 10:00 PM, the GLUT5 mRNA signal continued
to be detected predominantly in the mature lower to
mid-villus regions of sections from PBS-treated ani-
 .mals Fig. 5D and E, respectively . Following fruc-
tose exposure, the relative distribution of GLUT5
mRNA expression along the mature villus axis Fig.
.5C and F, respectively did not alter appreciably
when compared to the controls. GLUT5 mRNA was
not detectable in the jejunal crypts of the control
groups or following fructose administration in the
morning or evening. Using sense GLUT5 cRNA
probes as a negative control, no signal was observed
in any regions of the sections at any of the time
points studied. A representative in-situ sense cRNA
riboprobe control section is shown in Fig. 5G corre-
sponding to the 9:00 AM time point.
3.4. Epithelial localization of GLUT5 and GLUT2
expression
For GLUT5 and GLUT2 immunohistochemistry, a
representative section for all control data is shown in
 .Fig. 6A and B corresponding to 9:00 AM . Immuno-
histochemical analysis of GLUT5 protein demon-
strated expression to be confined to the brush-border
membrane of the mature villus. Throughout the diur-
nal period, no change in the membrane targeting or
villus distribution was observed for GLUT5 protein
expression. In addition, no expression of GLUT5
protein was detected from the crypt regions. Fig.
6C–E are representative sections taken from tissues
at 1:00 and 10:00 PM after 4 h of fructose exposure.
Following fructose exposure, GLUT5 protein expres-
sion remained confined to the mature villus regions
with no change in the membrane targeting or expres-
sion in the crypts observed.
Fig. 6F and G are tissue sections obtained from
animals exposed to fructose for 4 h between 9:00 AM
and 1:00 PM, respectively, and stained for GLUT2
protein expression. Clear basal-lateral staining of
GLUT2 protein along the entire mature villus axis
was observed during all control time points and
following fructose exposure. No detectable GLUT2
signal was observed from the crypt cells in either
 .control or fructose exposed tissue Fig. 6G . Im-
munohistochemistry involving stock rabbit sera were
run in parallel and generated no detectable signal
 .data not shown .
4. Discussion
Diurnal expression for a number of digestive activ-
ities, including the hexose transporters, has been
w xpreviously reported 8–10,26–35 . Concordant diur-
nal variations have also been determined for mouse
w xjejunal mitosis and DNA synthesis rates 16,17 . Di-
urnality therefore appears to be linked to the differen-
tiation process, whereby crypt cells become mature
enterocytes. The in-situ hybridization and immuno-
chemical data supports this by demonstrating expres-
sion of GLUT5 mRNA and protein at all times to be
confined to the mature villus regions with no de-
tectable contribution by the crypts. The diurnal con-
trol mechanisms remain unknown, although feeding
w x w xentrainment 17,26–35 neural 36 and systemic in-
w xfluences 32 have been implicated. In addition, it has
been suggested that a loss of repression at the tran-
scriptional level once the enterocyte crosses the
crypt-villus junction is responsible for the diurnal
w xincrease in expression 37 . The downturn in mRNA
expression between 6:00 and 10:00 PM may be a
result of enterocytes in the lower to mid villus re-
gions migrating toward the villus tips and thus pre-
programmed cell death.
The control PBS Northern and Western blot data
demonstrated a diurnal pattern of expression similar
w xto that observed for animals fed ad libitum 9,10 . In
w xagreement with others 35 , the absence of luminal
nutrients in the short term appears to have no effect
on the diurnal expression patterns. However, in the
long term, the nocturnal luminal load has been shown
to cue the diurnal expression of a number of digestive
w xactivities 27,29,30 . In support, we have data that
shows diurnality to be sensitive to the transit time of
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the meal. That is, when jejunal samples were isolated
over a 24 h control fed period, GLUT5 mRNA
expression levels were found to peak at 3:00 PM in
the proximal regions and 9:00 PM in the distal
regions C.P Corpe and C.F. Burant, unpublished
.data .
Previous studies have suggested that the crypt
enterocytes are the initial site of dietary perception
w x12,18 . However, no GLUT5 mRNA and protein or
GLUT2 protein was detected in the crypts in the
presence or absence of fructose. These data suggest
an inability by the crypts in the short term to trans-
port, sense and respond to fructose. However, it is
possible that fructose is sensed by the crypts but they
are unable to respond until they have migrated into
the mature villus regions. Premature activation of
hexose transporter mRNA in the crypts does occur
w xduring STZ-induced diabetes 14 , suggesting that
pathological increases in GLUT5 levels occur through
a different mechanism from diurnal and fructose-
mediated responses. Immunohistochemical analysis
of the mature villus demonstrated both GLUT5 and
GLUT2 protein expression. In contrast, GLUT5
mRNA expression predominated under all conditions
in the lower to mid villus regions. The data may
suggest an element of translational control in the
upper villus regions maintaining protein levels of
expression in the face of falling mRNA levels. In-
deed, similar observations for jejunal SGLT1 mRNA,
protein and transporter activity have been reported
w x38 .
The simplest explanation for the effects of cyclo-
heximide in the morning is that translation of as yet
unidentified factors is important for the diurnal and
fructose sensitive increase in GLUT5 mRNA expres-
sion. It is not clear whether the proposed factors are
effective at the transcriptional or postranscriptional
level. However, we hypothesize that the levels of the
 .proposed factor s increase during the day in concor-
dance with the diurnal pattern of hexose transporter
expression. The downturn in GLUT5 mRNA in the
evening, independent to new protein synthesis, may
reflect the finite life of the proposed diurnal control
factors synthesized earlier in the day. The ability of
fructose to increase GLUT5 mRNA in the evening,
largely independent to new protein synthesis, may
occur by fructose stabilizing the hypothesized diurnal
control factors. Alternatively, diurnal expression
could also include the synthesis of sugar sensitive
factors during the day. This would provide by late
afternoon an abundant pool of fructose sensitive fac-
tors for fructose to interact with rapidly. The small
difference in morning GLUT5 mRNA levels between
fructose plus cycloheximide and cycloheximide alone
is probably because diurnal expression begins at
w xaround 3:00 AM 10 . Thus, by 9:00 AM, there are
sufficient numbers of diurnalrfructose sensitive con-
trol factors available, albeit at low levels, for fructose
to interact with and stimulate expression.
w xIn ad libitum fed 10 and vehicle-gavaged rodents,
GLUT5 protein expression during the day lags be-
hind diurnal expression of GLUT5 mRNA. During
the evening, despite GLUT5 mRNA levels falling,
GLUT5 protein levels are maximal. This discordance
may reflect an alteration in the relative stabilities of
GLUT5 mRNA and protein during the day. Indeed,
cycloheximide in the evening had minimal effect on
GLUT5 protein expression levels when compared to
the morning. The decrease in turnover as the day
progresses may in part account for the diurnal upreg-
ulation of GLUT5 protein. Determining quantitatively
alterations in the half life of GLUT5 protein in
relation to diurnality and fructose feeding would be
of interest as it would suggest modulation of the
transporter by other proteins. It has previously been
suggested that fructose may enhance GLUT5 protein
w xlevels by stabilizing the protein in the membrane 11 .
Our data does not support this as we detected no
significant differences between fructose plus inhibitor
and inhibitor alone in either the morning or evening
studies.
In summary, the presented study indicates that
diurnality and short term fructose responsiveness is
confined to the mature enterocytes. In addition, we
present preliminary evidence that GLUT5 expression
is controlled by diurnally expressed factors that fruc-
tose may interact with directly. The identity and
molecular level at which these factors exert their
influence remains to be determined. We are ap-
proaching this problem using transgenic mouse tech-
nology and hope to determine if cis-acting elements,
responsible for diurnality, cephalo-caudal expression
and fructose responsiveness, exist. Such experiments
could ultimately lead to the cloning and characteriza-
tion of the trans-acting factors responsible for the
presented data.
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